| Pack Size/Qty | Price | Unit Price | |
| 9 Bottle/s | $46.50 | $5.20 | |
| 6 Bottle/s | $31.00 | $5.20 | |
| 3 Bottle/s | $15.60 | $5.20 |
Generic Name : Azthromycin Ophthalmic Solution
Brand Name : Azithral
Manufacturer Name : Alembic
Product Code : CRX 220
Delivery Days : 10 to 15 working days
Strength : 1 %
Packaging : Eye Drop (Bottle/s Packing)
Prescribed For : Eye Infections, Swelling, Injury, Surgery & Other Condition
Azithromycin Ophthalmic Solution, commonly known as Azithromycin Eye Drops, represents a breakthrough in ophthalmic medicine, catering to a myriad of ocular conditions with its potent antimicrobial properties and targeted delivery system. This innovative eye drop is a testament to the constant evolution in medical science, providing ophthalmologists and healthcare professionals a powerful tool to combat various eye infections. This comprehensive discussion delves into the characteristics, uses, mechanism of action, potential side effects, and future prospects of Azithromycin Ophthalmic Solution.
Azithromycin Ophthalmic Solution is formulated with azithromycin, a broad-spectrum macrolide antibiotic, renowned for its efficacy against a wide range of bacteria. The eye drop is presented in a sterile, isotonic, and buffered solution, ensuring optimal compatibility with the delicate structures of the eye. The formulation is often preserved with benzalkonium chloride to maintain sterility and prevent microbial contamination.
The solution typically comes in a convenient dropper bottle, designed for easy and precise instillation. The packaging ensures proper dosage control, facilitating accurate administration and minimizing the risk of overdose.
Azithromycin, the active ingredient in the ophthalmic solution, functions by inhibiting bacterial protein synthesis. It achieves this by binding to the 50S ribosomal subunit of susceptible bacteria, thereby preventing the translocation of peptides. This disruption in protein synthesis leads to the inhibition of bacterial growth and ultimately eradication.
The ophthalmic solution's local application ensures a targeted approach, delivering the antibiotic directly to the site of infection. This focused delivery minimizes systemic absorption, reducing the risk of systemic side effects often associated with oral antibiotics.
Azithromycin Ophthalmic Solution finds its application in the treatment of various ocular infections caused by susceptible bacteria. Common indications include bacterial conjunctivitis, a prevalent and contagious eye infection characterized by redness, discharge, and discomfort.
The eye drop is particularly advantageous in cases where topical antibiotics are preferred over systemic administration due to the localized nature of the infection. Additionally, Azithromycin Ophthalmic Solution is effective against both gram-positive and gram-negative bacteria, widening its spectrum of utility.
The administration of Azithromycin Ophthalmic Solution is a straightforward process, making it suitable for both healthcare professionals and patients. Prior to application, individuals are advised to wash their hands thoroughly to prevent contamination.
The recommended dosage regimen often involves instilling one to two drops into the affected eye(s) twice daily for a specified duration, as determined by the treating physician. It is imperative to adhere to the prescribed dosage and complete the entire course of treatment to ensure the eradication of the infection and prevent the development of antibiotic resistance.
While Azithromycin Ophthalmic Solution is generally well-tolerated, like any medication, it may be associated with certain side effects. Common side effects include temporary stinging or burning sensation upon instillation, blurred vision, and transient discomfort. These effects are typically mild and self-limiting.
Rare but more serious side effects may include allergic reactions such as itching, swelling, or severe eye irritation. If any adverse reactions persist or worsen, patients are advised to promptly seek medical attention.
Azithromycin Ophthalmic Solution is contraindicated in individuals with known hypersensitivity to azithromycin or any of its components. Additionally, caution is exercised in patients with a history of allergic reactions to other macrolide antibiotics.
Pregnant and breastfeeding women are advised to consult their healthcare providers before using the eye drops, as the potential risks and benefits must be carefully weighed.
In conclusion, Azithromycin Ophthalmic Solution stands as a formidable option in the armamentarium against ocular infections. Its targeted delivery system, coupled with the broad-spectrum antimicrobial properties of azithromycin, makes it a valuable tool for ophthalmologists and healthcare professionals.
As research in ophthalmic medicine continues to advance, the future may witness further refinements in formulations, potentially enhancing the efficacy and safety profile of Azithromycin Ophthalmic Solution. Continued exploration of its applications and potential use in novel therapeutic approaches may pave the way for even more sophisticated and tailored solutions in eye care.
In the ever-evolving landscape of pharmaceuticals, Azithromycin Ophthalmic Solution stands as a testament to the dedication to advancing medical science for the betterment of patient care, particularly in the realm of ocular health.
